As the various Canadian Cannabis companies jockey for position in the recreational marijuana market it’s time to consider which are best placed to meet the market strategically.
Here is another in my series of articles on the recreational marijuana industry in Canada. There is no doubt a lot of money to be made selling legal pot but the federal and provincial governments are not making it easy. The biggest hole in the regulatory scheme is the postponement of regulations dealing with edibles. In the US edibles have constituted up to 50% of the legal market. Companies have to adapt.
FSD Pharma Inc. (the “Company”) (CSE: HUGE), is pleased to announce that its wholly- owned subsidiary FV Pharma Inc (“FV Pharma”) have entered into a strategic alliance with SciCann Therapeutics Inc. (“SciCann”) by executing a binding Memorandum of Understanding (the “MOU“) dated May 28, 2018, pursuant to which FV Pharma shall invest up to $3M in SciCann for a 15% equity stake.